Next Article in Journal
Is There Enough Evidence to Support the Role of Glycosaminoglycans and Proteoglycans in Thoracic Aortic Aneurysm and Dissection?—A Systematic Review
Next Article in Special Issue
Association of Circulating Platelet Extracellular Vesicles and Pulse Wave Velocity with Cardiovascular Risk Estimation
Previous Article in Journal
mTOR: A Potential New Target in Nonalcoholic Fatty Liver Disease
Previous Article in Special Issue
The Role of Platelets in Diabetic Kidney Disease
 
 
Review
Peer-Review Record

Oxidised Low-Density Lipoprotein-Induced Platelet Hyperactivity—Receptors and Signalling Mechanisms

Int. J. Mol. Sci. 2022, 23(16), 9199; https://doi.org/10.3390/ijms23169199
by Martin Berger 1,* and Khalid M. Naseem 2
Reviewer 1:
Reviewer 2:
Int. J. Mol. Sci. 2022, 23(16), 9199; https://doi.org/10.3390/ijms23169199
Submission received: 2 July 2022 / Revised: 26 July 2022 / Accepted: 9 August 2022 / Published: 16 August 2022
(This article belongs to the Special Issue Advances in Platelet Biology and Functions)

Round 1

Reviewer 1 Report

ijms-1823497-Revision

Berger and Naseem aim with this review to summarise recent advances of the pro-thrombotic signalling events induced in platelets by modified LDL ligation, describing the contribution of individual platelet scavenger receptors and highlighting the potential future challenges of targeting these pathways.

The ability to understand and modulate mechanisms governing interactions between LDL-cholesterol and platelets may offer new treatment strategies for atherosclerosis prevention.

Given that the mechanisms underlying platelet activation in atherosclerosis are still incompletely understood, several major points must be define for pubblication.

1.          The role of platelet-derived extracellular vesicle which disseminate the procoagulant and proinflammatory effects of activated platelets, thus contributing to platelet interactions with other cells and with ox-LDL particles, must be described.

2.          The interactions between platelets and ox-LDL affect several cell population, including inflammatory cells, endothelial cells and foam cell generation, all of which contribute to atherosclerosis. These interaction must be insert.

3.          A more attracting and clear figure coud be provide.

ijms-1823497-Revision

Berger and Naseem aim with this review to summarise recent advances of the pro-thrombotic signalling events induced in platelets by modified LDL ligation, describing the contribution of individual platelet scavenger receptors and highlighting the potential future challenges of targeting these pathways.

The ability to understand and modulate mechanisms governing interactions between LDL-cholesterol and platelets may offer new treatment strategies for atherosclerosis prevention.

Given that the mechanisms underlying platelet activation in atherosclerosis are still incompletely understood, several major points must be define for pubblication.

1.          The role of platelet-derived extracellular vesicle which disseminate the procoagulant and proinflammatory effects of activated platelets, thus contributing to platelet interactions with other cells and with ox-LDL particles, must be described.

2.          The interactions between platelets and ox-LDL affect several cell population, including inflammatory cells, endothelial cells and foam cell generation, all of which contribute to atherosclerosis. These interaction must be insert.

3.          A more attracting and clear figure coud be provide.

ijms-1823497-Revision

Berger and Naseem aim with this review to summarise recent advances of the pro-thrombotic signalling events induced in platelets by modified LDL ligation, describing the contribution of individual platelet scavenger receptors and highlighting the potential future challenges of targeting these pathways.

The ability to understand and modulate mechanisms governing interactions between LDL-cholesterol and platelets may offer new treatment strategies for atherosclerosis prevention.

Given that the mechanisms underlying platelet activation in atherosclerosis are still incompletely understood, several major points must be define for pubblication.

1.          The role of platelet-derived extracellular vesicle which disseminate the procoagulant and proinflammatory effects of activated platelets, thus contributing to platelet interactions with other cells and with ox-LDL particles, must be described.

2.          The interactions between platelets and ox-LDL affect several cell population, including inflammatory cells, endothelial cells and foam cell generation, all of which contribute to atherosclerosis. These interaction must be insert.

3.          A more attracting and clear figure coud be provide.

Comments for author File: Comments.docx

Author Response

We would like to thank the reviewer for their comments. Please find our reply attached. 

Author Response File: Author Response.docx

Reviewer 2 Report

The Manuscript: „ Oxidised low density lipoprotein induced platelet hyperactivity – receptors and signalling mechanism’’ by Berger and Naseem summarises recent advances in the understanding of pro-thrombotic signalling events induced in platelets by modified LDL ligation and describes the contribution of individual platelet scavenger receptors. OxLDL generated in the hyperlipidemic state are generally known to contribute to unregulated platelet activation during thrombosis and stimulate platelet activation through phosphorylation of the regulatory light chains of the contractile protein myosin IIa (MLC). OxLDL are also reported to be involved in various diseases, including cardiovascular diseases and atherogenesis.

The submitted manuscript nicely reviews ample literatures addressing the biochemical mechanisms translating atherogenic lipid stress in the form of oxLDL. After going through the manuscript, I have a couple of comments for the authors:

1.      Oxidative stress is known to be an important risk factor for the pathogenesis of various diseases. Please discuss with relevant reference(s) how oxidation of LDL contributes in pathogenesis of different diseases.

2.      OxLDL is also used to measure the protein damage due to the oxidative modification of the ApoB subunit on LDL cholesterol. Please briefly discuss this point in the manuscript.

Author Response

We would like to thank the reviewer for their comments. Please find our reply attached. 

Author Response File: Author Response.docx

Round 2

Reviewer 1 Report

The role of the reviewer is improve the scientific interest of the manuscript/review.

Any considerations/suggestions of reviewer has been included in your revision.

Back to TopTop